TABLE 2

Sites of Disease Recurrence on PSMA PET

SiteData
None90/260 (34.6%)
Fossa56/260 (21.5%)
Pelvic lymph nodes68/260 (26.2%)
Distant lymph nodes16/260 (6.2%)
Bone metastases25/260 (9.6%)
Visceral metastases5/260 (1.9%)